Latinos are not proportionally represented in research, nursing, and doctoral fields, even though they make up 20% of the U.S. population. The Éxito! program aimed to fill that gap. Éxito!, created by Dr. Amelie G. Ramirez of the Institute for Health Promotion Research (IHPR) at UT Health San Antonio, recruited 226 students and health professionals over 11 years for a culturally tailored curriculum to promote pursuit of a doctoral degree and Latino cancer research career. With the 20th anniversary of the IHPR on Oct. 1, 2026, now is a good time to check in and see some Éxito! trainees have progressed!
About the Éxito! Program at the IHPR
Each year from 2011 to 2021, the IHPR’s Éxito! program hosted a five-day summer institute in San Antonio, Texas. The event ...
Become a politician? Work in a health ministry? As a young girl growing up in Colombia, Dr. Marcela Mazo Canola wasn’t sure exactly what she wanted to be — but she dreamed of making a difference for people. Today, Mazo Canola is helping others as a breast medical oncologist at Mays Cancer Center at UT Health San Antonio and contributing to research to improve cancer and health outcomes for Latinos and all populations. “Although I’m in a different career that I love very much, I guess I still ended up doing something similar to what I was dreaming of when I was a little girl,” she said. During Hispanic Heritage Month, Salud America! is highlighting heroes in healthcare and throughout the community who strive to make a difference. Let’s take closer look into Dr. ...
With cancer still a top health threat, UT Health San Antonio leaders and national cancer experts have published an online book with innovative recommendations to reduce cancer among Latinos and all people. The book, “Advancing Cancer Research for Latinos and All Populations: 2026 Conference Proceedings,” highlights results of the same-named conference that brought 350 researchers, advocates, and survivors to San Antonio in February 2026. A follow-up conference is planned for Feb. 23-25, 2028, in San Antonio. Included in the book are promising research findings on Latino cancer and strategies for new research covering the entire cancer continuum. This includes advances in genetics, prevention, screening, detection, treatment, survivorship, and policy, said Dr. Amelie ...
Cancer is a threat to the health of Latinos and all people. That’s why Dr. Amelie Ramirez, director of Salud America! and the Institute for Health Promotion Research at UT Health San Antonio, partnered with the Mays Cancer Center to create the Advancing Cancer Research for Latinos and All Populations (ACRLP) biennial conference series. On Feb. 18-20, 2026, the newest ACRLP conference welcomed over 350 prominent researchers, physicians, healthcare professionals, patient advocates, and students from across the globe to address cancer among Latinos and all people in San Antonio, Texas. Conference sponsors included: Genentech, Bristol Myers Squibb, Gilead, Revolution Medicine, Natera, AstraZeneca (platinum); Blood Cancer United, Menarini Stemline, Eli Lilly (gold); National ...
The U.S. is home to many Latinos and other people with different backgrounds, but many suffer unfair health challenges and heavy burdens of cancer and dementia. More research needs to be done to understand the impact, vulnerabilities, and risks these communities face.
To accurately study the health consistencies in these groups, more of them need to participate in clinical research and clinical trials, which are studies with volunteers that test ways to find, prevent, and treat cancer and other diseases.
As of 2023, only 6% of trials being conducted to get FDA drug approval reflected the variety in the U.S. population, according to a new study published in Communications Medicine.
Let’s dive into the study and how to improve clinical trial enrollment. Study Findings on Clinical ...
The cost of cancer is a steep one. The impact of a cancer diagnosis goes beyond physical, mental, and emotional factors to include a hefty treatment price tag that few can afford. But with their lives at stake, cancer patients can’t afford not to pay. The reality is that many cancer patients are facing treatment costs that rival the worth of most people’s homes. A new study from the researchers at the American Cancer Society (ACS) and published in the JNCI: Journal of the National Cancer Institute found that cancer-related expenses differ greatly depending on cancer type, stage, and phases of care. Let’s go over these findings and the importance of early detection and intervention, including cancer screenings, for Latinos and ...
This content is from UT Health San Antonio’s book, “Advancing Cancer Research for Latinos and All Populations: 2026 Conference Proceedings,” which highlights results of the same-named conference in February 2026. Dr. Robert A. Winn, MD, is the former Director and Lipman Chair in Oncology at VCU Massey Comprehensive Cancer Center.
Science for a purpose Dr. Winn began by praising recent scientific and medical advances, but also by emphasizing that those advances need to make a difference for everyday people in everyday communities. About 1 in 2 men and 1 in 3 women are diagnosed with cancer in their lifetime. Much of the information about risk, and information about advances in medicine, have failed to reach more rural populations, and even some of their primary care ...
This content is from UT Health San Antonio’s book, “Advancing Cancer Research for Latinos and All Populations: 2026 Conference Proceedings,” which highlights results of the same-named conference in February 2026.
Variability of cancer outcomes based on population
Cancer rates and outcomes vary widely based on race/ethnicity, gender, country of origin, location, heritage, language spoken, socioeconomic status, age, family history, and more. For example, although Latino individuals have lower overall rates of cancer nationwide, rates of stomach and liver cancer are twice as high as non-Hispanic White individuals, and the rate of cervical cancer is 36% higher. [Winn] Because of this variability, intentional steps must be taken to ensure cancer research and initiatives target all ...
This content is from UT Health San Antonio’s book, “Advancing Cancer Research for Latinos and All Populations: 2026 Conference Proceedings,” which highlights results of the same-named conference in February 2026.
The Hidden Costs of Care: Tackling Financial Toxicity in Oncology
Dr. Jean Edward is Associate Professor and PhD Program Director for the College of Nursing at the Markey Cancer Center and the University of Kentucky. Financial toxicity and Hispanic cancer survivors Dr. Edward began by defining financial toxicity as the financial burden and distress associated with the high costs of cancer care. Approximately 30% of cancer survivors experience financial toxicity. Overall, cancer survivors spend about 20% of their income on out-of-pocket expenses, and are 2.65 ...
